Eli Lilly’s Animal Division Reports 20% Q4 Increase



Published:

Eli Lilly and Co.’s animal health division reported revenue of $424.3 million for its fourth quarter ended Dec. 31, up 20 percent compared to revenue of $353.1 million in the year-ago period.

U.S. sales grew 25 percent to $234.5 million, due to increased demand, according to the Indianapolis-based company. Sales outside the U.S. increased 15 percent to $189.8 million, driven by increased demand and the impact of a recent acquisition, the company reported.

Year to date, the division reported revenue of $1.4 billion, compared to revenue of $1.2 percent in the year-ago period.

Animal health sales in the U.S. and outside the U.S. increased 15 percent to $775.1 million and $616.3 million, respectively, driven primarily by increased demand, according to the company.

Overall, Eli Lilly and Co. reported net income of $1.2 billion on revenue of $6.2 billion for its fourth quarter, compared to net income of $915.4 million on revenue of $5.9 billion in the year-ago period.

Year to date, the company reported net income of $5.1 billion on revenue of $23.1 billion, compared to net income of $4.3 billion on revenue of $23.8 billion in the year-ago period.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Study May Lead to Early Diagnosis of Feline Kidney Disease

The biomarker SDMA identified the onset of kidney disease an average of 17 months earlier in cats and in one case four years earlier.

Merck Launches Overseas Veterinarian Exchange

The Nobivac Global Vet Exchange Program allows practitioners to observe how veterinary medicine is performed in other countries.

Petco Buying Drs. Foster and Smith

Co-founders Race Foster and Marty Smith will stay with Drs. Foster and Smith when Petco takes ownership and branches into drug sales in early 2015.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module